Justice DY Chandrachud led bench will shortly hear the #suomotu case regarding COVID vaccine pricing issues, #oxygen supply & supply of essential medicines.
Centre has told the #SupremeCourt that new liberalised pricing policy for COVID vaccine adopted is to ensure scaling up of vaccine coverage, to incentivize vaccine manufacturers to rapidly scale up their production and to attract new vaccine manufacturers
During the hearing of the matter on April 30, the top court had questioned the government on vaccine pricing, remarking that vaccines which states have to procure are overpriced. #SupremeCourt#covidvaccine@SerumInstIndia@BharatBiotech
Centre submits that citizens of 18 to 44 years are also getting vaccination free of cost as all the State governments have announced free vaccination for this population group of 18-44 years. Thus, all citizens of all age groups will get #free vaccination
Central government said that though it is duty bound to fully assist the Supreme Court, no interference is called for by way of judicial proceedings .
"Any overzealous, though well-meaning judicial intervention may lead to unforeseen and unintended consequences," Centre tells SC
Justice DY Chandrachud: We got the centre's affidavit late at night. my brothers got it at 10 am and Justice Rao got it through affidavit. I read the Indian Express and they had it the affidavit before us.
In the pleading, we had sought interim bail on the ground that the father is down with #COVID19. Unfortunately, he passed away last evening. The brother also has COVID: Adv Adit Pujari for Natasha Narwal.